Medytox
Newlux
Brand
Medytox
Category
Botulinum Toxin
Origin
Korea
Options
100 unit
Available options
Interested in ordering Newlux? Send an enquiry and our team will follow up with availability and pricing.
Overview
Newlux is a botulinum toxin type A injectable from South Korea's Medytox, launched in 2023 through a subsidiary and approved by Korea's MFDS. It is positioned as a premium, high-purity neurotoxin and is notable for being produced without animal-derived components, which is intended to reduce the risk of animal-antigen-related reactions. It is supplied as a lyophilised 100 unit vial.
How it works
Botulinum toxin type A binds to presynaptic cholinergic nerve terminals and cleaves the SNAP-25 protein, blocking acetylcholine release at the neuromuscular junction. This temporarily relaxes the target muscle and reduces dynamic wrinkling. The effect is reversible as nerve function recovers.
Indications
- Glabellar (frown) lines
- Forehead lines
- Crow's feet
- Masseter slimming
- Other dynamic facial wrinkles
Key features
- Medytox portfolio toxin (2023 launch)
- MFDS (Korea) approved
- Manufactured without animal-derived components
- High-purity type A complex
- Lyophilised 100U vial
Benefits
- Animal-component-free process to help limit allergenicity
- Backing of an established toxin manufacturer
- High purity for a controlled immunogenic profile
- Consistent unit dosing
Composition
Botulinum toxin type A supplied as a lyophilised 100 unit vial, formulated with human serum albumin and sodium chloride as excipients and produced without animal-derived components. Distributors cite high purity (reported above 99%).
Usage & handling
Reconstitute the lyophilised powder with preservative-free 0.9% sterile saline to yield a clear solution before injection. Store refrigerated at 2-8C and use promptly after reconstitution per label. For administration by trained practitioners only.
For medical professionals. Product information is for reference and does not replace the manufacturer's instructions for use. Availability and regulatory status vary by region.